Drugs & TargetsFree Amgen Inc. and Xencor Inc. enters immunotherapy research agreement September 25, 2015Vol.41 No.35
Free Information Blocking by E-Health Record Firms Threatens CancerLinQ, ASCO Says September 25, 2015Vol.41 No.35By Paul Goldberg
FreeIn Brief Robert Schreiber, Philip Greenberg named editors-in-chief of Cancer Immunology Research September 25, 2015Vol.41 No.35
Drugs & TargetsFree CTI BioPharma Corp. plans to submit NDA for pacritinib September 25, 2015Vol.41 No.35
Drugs & TargetsFree Roche NimbleGen introduces enhanced whole exome sequencing solution for medical and translational research September 25, 2015Vol.41 No.35
Drugs & TargetsFree ICON teams up with IBM to reduce time and costs of drug development September 18, 2015Vol.41 No.34
Drugs & TargetsFree AstraZeneca and Peregrine Pharmaceuticals enter into immunotherapy clinical trial collaboration September 18, 2015Vol.41 No.34
Drugs & TargetsFree FDA and the European Medicines Agency accepts regulatory applications for Gilotrif September 18, 2015Vol.41 No.34
Drugs & TargetsFree FDA accepts Wellstat Therapeutics’ NDA for treatment of chemotherapy overdose September 18, 2015Vol.41 No.34
